Levosulpirida [Inn-Spanish]
Category
Levosulpirida [Inn-Spanish] Brand names, Levosulpirida [Inn-Spanish] Analogs
Levosulpirida [Inn-Spanish] Brand Names Mixture
Levosulpirida [Inn-Spanish] Chemical_Formula
C15H23N3O4S
Levosulpirida [Inn-Spanish] RX_link
No information avaliable
Levosulpirida [Inn-Spanish] fda sheet
Levosulpirida [Inn-Spanish] msds (material safety sheet)
Levosulpirida [Inn-Spanish] Synthesis Reference
No information avaliable
Levosulpirida [Inn-Spanish] Molecular Weight
341.427 g/mol
Levosulpirida [Inn-Spanish] Melting Point
178 oC
Levosulpirida [Inn-Spanish] H2O Solubility
2280 mg/L
Levosulpirida [Inn-Spanish] State
Solid
Levosulpirida [Inn-Spanish] LogP
1.337
Levosulpirida [Inn-Spanish] Dosage Forms
Tablet
Levosulpirida [Inn-Spanish] Indication
Sulpiride is indicated for the treatment of schizophrenia.
Levosulpirida [Inn-Spanish] Pharmacology
Sulpiride is a substituted benzamide derivative and a selective dopamine D2 antagonist with antipsychotic and antidepressant activity. Other benzamide derivatives include metoclopramide, tiapride, and sultopride.
Levosulpirida [Inn-Spanish] Absorption
No information avaliable
Levosulpirida [Inn-Spanish] side effects and Toxicity
No information avaliable
Levosulpirida [Inn-Spanish] Patient Information
No information avaliable
Levosulpirida [Inn-Spanish] Organisms Affected
Humans and other mammals